B-MS to Build Near-$1 Billion Biologics Facility in Ireland

Friday, November 14, 2014

Source: PharmaTimes Digital

Bristol-Myers Squibb has unveiled plans to construct a new biologics manufacturing facility in Ireland which will create up to 400 new jobs as part of a near $1 billion investment.

The 30,000-square metre project will house six bioreactors and a purification area as well as office and laboratory space. It will be built on the grounds of the company’s existing bulk pharmaceutical manufacturing plant in Cruiserath, Co Dublin.

View All News »